©2012 Baishideng Publishing Group Co.
World J Hepatol. Dec 27, 2012; 4(12): 382-388
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Table 1 Criteria used for histological scoring[21]
| Steatosis: |
| 0 : None |
| 1: up to 33% |
| 2: 33%-66% |
| 3: > 66% |
| Hepatocyte ballooning |
| 0: None |
| 1: Occasional, Zone 3 |
| 2: “Obvious” Zone 3 |
| 3: Marked, predominantly Zone 3 |
| Mallory bodies |
| 0: No Mallory bodies |
| 1: Fewer than two in 10 to 20 × fields |
| 2: More than two in 10 to 20 × fields |
| Glycogenated nuclei |
| 0: Absent |
| 1: Occasional |
| 2: Several |
| Lobular inflammation (inflammatory foci per 20 × with a 20 × ocular) |
| 0: None |
| 1: 1 to 2/20 |
| 2: Up to 4/20 |
| 3: More than 4/20 |
| Portal inflammation |
| 0: None |
| 1: Mild |
| 2: Moderate |
| 3: Severe |
| Fibrosis score: |
| Stage 0: No fibrosis |
| Stage 1: Zone 3 perisinusoidal/pericellular fibrosis; focally or extensively present |
| Stage 2: Zone 3 perisinusoidal/pericellular fibrosis with focal or extensive periportal fibrosis |
| Stage 3: Zone 3 perisinusoidal/pericellular fibrosis and portal fibrosis with a focal or extensive bridging fibrosis |
| Stage 4: Cirrhosis |
- Citation: Vargas V, Allende H, Lecube A, Salcedo MT, Baena-Fustegueras JA, Fort JM, Rivero J, Ferrer R, Catalán R, Pardina E, Ramón y Cajal S, Guardia J, Peinado-Onsurbe J. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol 2012; 4(12): 382-388
- URL: https://www.wjgnet.com/1948-5182/full/v4/i12/382.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i12.382